[Investigations of drugs from regional centers]

Quantitative pharmacogenetics of nortriptyline: a novel approach.

Clinical pharmacokinetics·2001

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.

The Journal of antimicrobial chemotherapy·2000

[Place of residence determines access to interferon-beta therapy in MS. Less than 15 per cent of patients are treated--big differences between the counties].

Lakartidningen·2000

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19).

European journal of clinical pharmacology·1999

The efficiency concept in pharmacodynamics.

Clinical pharmacokinetics·1999

The influence of drug input rate on the development of tolerance to frusemide.

British journal of clinical pharmacology·1998

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

Lakartidningen·2026

[Rare manifestations of giant cell arteritis].

Lakartidningen·2026

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

Lakartidningen·2026

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

Lakartidningen·2026

[Postoperative atrial fibrillation after open heart surgery].

Lakartidningen·2026

[Interaction between psychotic patients and AI-driven chatbots].

Lakartidningen·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026

Related Experiment Videos

[Investigations of drugs from regional centers]

Related Concept Videos

Quantitative pharmacogenetics of nortriptyline: a novel approach.

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.

[Place of residence determines access to interferon-beta therapy in MS. Less than 15 per cent of patients are treated--big differences between the counties].

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19).

The efficiency concept in pharmacodynamics.

The influence of drug input rate on the development of tolerance to frusemide.

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

[Rare manifestations of giant cell arteritis].

[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].

[The Swedish Neonatal Quality Register (SNQ) - a complete register for a complex chain of events].

[Postoperative atrial fibrillation after open heart surgery].

[Interaction between psychotic patients and AI-driven chatbots].

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Related Experiment Videos

[Investigations of drugs from regional centers]

Related Concept Videos

Related Articles